Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Funds Make Big After Regeneron $REGN Gets FDA OK for Eylea

Regeneron Pharmaceuticals Inc.’s (REGN) shares rose 13.73% in trading on Monday after U.S. regulators approved its “drug Eylea to treat a leading cause of blindness in the elderly, handing the company a second product to sell and inserting a market challenger to Roche Holding AG (RHHBY, ROG.VX),” reports the Wall Street Journal. “Shares in Regeneron were halted before the news. The stock closed Friday down 2.6% at $49.81.” REGN was trading at $56.65 at 1:40pm EST Monday.

Leonard S. Schleifer, Regeneron Chief Executive, said Friday that REGN, “planned to make Eylea available to patients ‘within the next few days’ after the U.S. Food and Drug Administration approved it to treat wet age-related macular degeneration.”

Chuck Royce

The following hedge funds made the most on the news:

1. Qvt Financial – Daniel Gold: Gained $2.1 million

2. Royce & Associates – Chuck Royce: Gained $684,000

3. Orbimed Advisors – Samuel Isaly: Gained $527,000

4. Highbridge Capital Management – Glenn Russell Dubin: Gained $372,000

5. D E Shaw – D. E. Shaw: Gained $236,000

6. Hbk Investments – David Costen Haley: Gained $196,000

7. Sac Capital Advisors – Steven Cohen: Gained $107,000

8. Millennium Management – Israel Englander: Gained $90,000

9. Aqr Capital Management – Cliff Asness: Gained $44,000

10. Citadel Investment Group – Ken Griffin: Gained $3,300

DISCLAIMER: These calculations assume that these hedge funds did not increase or reduce their stock positions in REGN since the end of June. We did not take into account their option positions.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading...